Ind-Swift Laboratories Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 7,49,983 shares,. Its Average Traded Price (ATP) is ₹395.43, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹395.15.
Ind-Swift Laboratories has an upper circuit limit of ₹474.15 and a lower circuit limit of ₹316.15. The total value traded stands at ₹29.66 CR, and the delivery percentage for the day is 46.99%.
The stock is currently traded with a market lot size of 1. Ind-Swift Laboratories also offers a dividend yield of 0%.
Ind-Swift Laboratories Share Price Chart
Ind-Swift Laboratories Share Key Metrics
Volume
7.50 L
Market Cap
3436.29 CR
LTQ@LTP
1@395.15
ATP
395.43
Var Margin
100 %
Circuit Range
316.15-474.15
Delivery %
46.99 %
Value
29.66 CR
ASM/GSM
No
Market Lot
1
Ind-Swift Laboratories Resistance and Support
Pivot 398.5
Resistance
First Resistance
415
Second Resistance
441.25
Third Resistance
457.75
Support
First Support
372.25
Second Support
355.75
Third Support
329.5
Ind-Swift Laboratories Shareholding Pattern
View More- 2016-17
- 2017-18
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Ind-Swift Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-07-10 | To consider issue of Warrants |
| 2026-05-28 | Audited Results |
| 2026-01-31 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
| 2025-02-12 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Ind-Swift Laboratories News
Ind-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Ind Swift Labs has scheduled an analyst and institutional investor meeting with Arihant Capital on September 29, 2026. The virtual group meeting will not involve sharing any unpublished price sensitive information.
Sep 23 2026 17:17:02
Ind-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ind Swift Laboratories' promoter and promoter group, led by Essix Biosciences, acquired 70 lakh fully convertible warrants. This acquisition increases their potential diluted shareholding from 43.06% to 47.18% on a preferential basis.
Sep 22 2026 11:13:56
Ind-Swift Laboratories Ltd - 532305 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
Ind Swift Laboratories' promoter group, including Essix Biosciences, acquired 70 lakh fully convertible warrants on a preferential basis. This transaction, executed on September 17, 2026, increased the promoter group's total diluted shareholding from 43.06% to 47.18%, signaling increased commitment.
Sep 21 2026 18:11:12
Ind-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Allotment
Ind Swift Laboratories has allotted 70 lakh fully convertible warrants to Essix Biosciences Limited, a promoter group entity. The warrants were issued at an issue price of Rs. 196 per warrant, with Rs. 34.3 crore received upfront.
Sep 17 2026 17:45:33
Ind-Swift Laboratories Ltd - 532305 - Outcome Of Preferential Issue Committee Meeting Held On Friday, 4Th September, 2026, As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Ind Swift Laboratories' Preferential Issue Committee has set the issue price for preferential allotment of warrants at Rs. 196 each. This decision incorporates a revised valuation report and complies with SEBI ICDR Regulations.
Sep 04 2026 15:01:37
Ind-Swift Laboratories Management
| Name | Position |
|---|---|
| Pardeep Verma | VP-Corp. Affairs, Company Secretary & Compliance Officer |
| Navrattan Munjal | Chairman & Managing Director |
Ind-Swift Laboratories Similar Stocks
Aarti Drugs Ltd.
421.00
-9.90 (2.30%)
Kwality Pharmaceuticals Ltd.
3564.40
-77.00 (2.11%)
Indraprastha Medical Corporation Ltd.
338.60
-10.35 (2.97%)
Solara Active Pharma Sciences Ltd.
714.85
-10.55 (1.45%)
Advanced Enzyme Technologies Ltd.
274.25
-7.35 (2.61%)
Hikal Ltd.
218.14
0.25 (0.11%)
Shukra Pharmaceuticals Ltd.
61.80
-0.29 (0.47%)
Dishman Carbogen Amcis Ltd.
150.35
-7.12 (4.52%)
Ind-Swift Laboratories FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDSWFTLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in INDSWFTLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade